KROS RSI Chart
Last 7 days
-10.2%
Last 30 days
-10.1%
Last 90 days
-10.8%
Trailing 12 Months
12.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 10.1M | 6.8M | 3.5M | 151.0K |
2022 | 0 | 16.8M | 13.5M | 0 |
2021 | 0 | 13.4M | 16.7M | 20.1M |
2019 | 10.0M | 10.0M | 10.0M | 10.0M |
2018 | 0 | 0 | 0 | 10.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 04, 2023 | regnante keith | sold | -1,811,600 | 45.29 | -40,000 | chief financial officer |
Nov 04, 2023 | regnante keith | acquired | 640,000 | 16.00 | 40,000 | chief financial officer |
Jun 09, 2023 | regnante keith | sold | -908,367 | 45.4184 | -20,000 | chief financial officer |
Jun 09, 2023 | regnante keith | acquired | 320,000 | 16.00 | 20,000 | chief financial officer |
Jun 08, 2023 | regnante keith | acquired | 320,000 | 16.00 | 20,000 | chief financial officer |
Jun 08, 2023 | regnante keith | sold | -955,872 | 47.7936 | -20,000 | chief financial officer |
Apr 08, 2023 | seehra jasbir | acquired | 1,920 | 0.48 | 4,000 | chief executive officer |
Nov 29, 2022 | kariv tomer | sold | -0.7176 | 0.0001 | -7,176 | - |
Nov 29, 2022 | nussbaum ran | sold | -0.7176 | 0.0001 | -7,176 | - |
Nov 29, 2022 | pontifax management 4 g.p. (2015) ltd. | sold | -0.7176 | 0.0001 | -7,176 | - |
Which funds bought or sold KROS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | Ameritas Investment Partners, Inc. | added | 14.49 | 80,569 | 169,472 | 0.01% |
May 13, 2024 | CIBC WORLD MARKETS CORP | new | - | 13,240,000 | 13,240,000 | 0.09% |
May 13, 2024 | Rafferty Asset Management, LLC | added | 83.07 | 5,316,060 | 7,911,630 | 0.03% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 16.78 | 19,162,300 | 39,450,400 | -% |
May 13, 2024 | UBS Group AG | reduced | -31.54 | 1,009,180 | 8,221,050 | -% |
May 13, 2024 | READYSTATE ASSET MANAGEMENT LP | new | - | 6,247,490 | 6,247,490 | 0.09% |
May 13, 2024 | Jefferies Financial Group Inc. | added | 3,885 | 41,316,800 | 41,949,000 | 0.39% |
May 13, 2024 | NATIONAL BANK OF CANADA /FI/ | reduced | -66.67 | -750 | 543 | -% |
May 13, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 13.09 | 392,794 | 837,629 | -% |
May 13, 2024 | CANADA LIFE ASSURANCE Co | added | 117 | 250,000 | 345,000 | -% |
Unveiling Keros Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Keros Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 49.2B | 6.8B | -8.24 | 7.18 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.7B | 2.0B | -56.37 | 9.34 | ||||
BMRN | 15.1B | 2.5B | 73.61 | 6.12 | ||||
INCY | 12.8B | 3.8B | 17.19 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.93 | 48.09 | ||||
APLS | 5.0B | 524.1M | -11.99 | 9.55 | ||||
AXSM | 3.7B | 251.0M | -12.4 | 14.64 | ||||
ARWR | 2.8B | 240.7M | -6.04 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.4K | 3.01 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.9B | 996.6M | -4.75 | 1.9 | ||||
CRBP | 456.3M | 881.7K | -13.52 | 481.06 | ||||
INO | 297.2M | 4.9M | -2.38 | 61.07 | ||||
IBIO | 16.2M | 2.1M | -0.7 | 7.61 |
Keros Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q3 | 2022Q2 | 2021Q4 | 2021Q3 | 2021Q2 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -89.7% | 83,000 | 807,400 | 1,531,800 | 2,256,200 | 2,980,600 | 3,705,000 | 3,376,000 | 3,157,000 | 2,938,000 | 2,719,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | - |
Operating Expenses | 4.2% | 48,566,000 | 46,598,000 | 43,288,000 | 41,337,000 | 38,869,000 | 27,976,000 | 30,728,000 | 24,866,000 | 20,197,000 | 15,641,000 | 5,228,000 | 4,826,000 | 5,151,000 | 5,358,000 | - |
S&GA Expenses | -100.0% | - | 9,105,000 | 9,148,000 | 8,803,000 | 7,778,000 | 6,937,000 | 7,447,000 | 6,033,000 | 5,365,000 | 5,658,000 | 1,067,000 | 972,000 | 654,000 | 491,000 | - |
R&D Expenses | 2.0% | 38,258,000 | 37,493,000 | 34,140,000 | 32,534,000 | 31,091,000 | 21,039,000 | 23,281,000 | 18,833,000 | 14,832,000 | 9,983,000 | 4,161,000 | 3,854,000 | 4,497,000 | 4,867,000 | - |
EBITDA Margin | 0% | -1,007 | -1,007 | -29.92 | -15.30 | -10.27 | -5.89 | -4.54 | -2.80 | -3.71 | -4.03 | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | 1,000 | 1,000 | 1,000 | - | 3,000 | 2,000 | 2,000 | - |
Income Taxes | - | - | - | - | - | - | - | - | 1,999,000 | -38,000 | - | - | - | - | - | - |
Earnings Before Taxes | - | - | - | - | - | - | -23,509,000 | -27,266,000 | -4,941,000 | -20,335,000 | -15,622,000 | -2,751,000 | -3,549,000 | -2,853,000 | -3,183,000 | - |
EBT Margin | 0% | -1,013 | -1,013 | -30.12 | -15.39 | -10.34 | -5.94 | -4.57 | -2.82 | -3.73 | -4.05 | - | - | - | - | - |
Net Income | -7.1% | -43,114,000 | -40,243,000 | -39,440,000 | -37,505,000 | -35,804,000 | -23,509,000 | -27,266,000 | -6,940,000 | -20,297,000 | -15,622,000 | -2,751,000 | -3,549,000 | -2,853,000 | -3,183,000 | - |
Net Income Margin | -4.8% | -1,061 | -1,013 | -40.99 | -18.61 | -11.49 | -6.09 | -4.69 | -2.92 | -3.73 | -4.06 | - | - | - | - | - |
Free Cashflow | -75.0% | -45,506,000 | -26,000,000 | -34,532,000 | -31,143,000 | -35,297,000 | -24,778,000 | -23,157,000 | -19,724,000 | -14,586,000 | -18,147,000 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Assets | 31.3% | 486 | 370 | 326 | 356 | 384 | 307 | 253 | 227 | 235 | 255 | 230 | 243 | 258 | 269 | 138 | 150 | 61.00 | 11.00 | 27.00 |
Current Assets | 33.4% | 463 | 347 | 304 | 334 | 362 | 286 | 246 | 222 | 231 | 251 | 226 | 241 | 256 | 268 | 136 | 149 | 59.00 | 9.00 | 26.00 |
Cash Equivalents | 34.0% | 444 | 331 | 288 | 322 | 351 | 279 | 239 | 216 | 229 | 230 | 221 | 237 | 255 | 266 | 134 | 145 | 55.00 | 7.00 | 23.00 |
Net PPE | 7.3% | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -15.7% | 32.00 | 38.00 | 30.00 | 30.00 | 29.00 | 29.00 | 12.00 | 15.00 | 12.00 | 12.00 | 11.00 | 8.00 | 9.00 | 8.00 | 7.00 | 9.00 | 10.00 | 10.00 | 15.00 |
Current Liabilities | -23.2% | 19.00 | 24.00 | 17.00 | 16.00 | 15.00 | 17.00 | 12.00 | 15.00 | 12.00 | 12.00 | 11.00 | 8.00 | 9.00 | 7.00 | 7.00 | 8.00 | 9.00 | 4.00 | 11.00 |
Shareholder's Equity | 36.6% | 454 | 332 | 296 | 326 | 355 | 277 | 241 | 211 | 223 | 243 | 218 | 236 | 248 | 262 | 131 | 141 | - | - | - |
Retained Earnings | -11.3% | -424 | -381 | -341 | -301 | -264 | -228 | -198 | -175 | -147 | -123 | -116 | -96.52 | -80.90 | -65.01 | -54.33 | -42.30 | -31.54 | -19.65 | -7.31 |
Additional Paid-In Capital | 23.1% | 878 | 714 | 637 | 628 | 619 | 506 | 440 | 386 | 371 | 367 | 335 | 332 | 329 | 327 | 185 | 184 | 7.00 | 0.00 | 0.00 |
Shares Outstanding | 13.3% | 36.00 | 32.00 | 30.00 | 30.00 | 30.00 | 28.00 | 25.00 | 24.00 | 24.00 | 23.00 | 23.00 | 23.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 905 | - | - | - | 471 | - | - | - | 657 | - | - | - | 386 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -75.0% | -44,560 | -25,459 | -33,982 | -30,832 | -34,235 | -21,443 | -24,602 | -22,590 | -1,427 | -19,565 | -14,441 | -17,637 | -10,505 | -7,991 | -10,856 | -9,927 | -8,120 | -5,498 | -2,955 | -5,032 | -2,513 |
Share Based Compensation | 10.2% | 8,070 | 7,324 | 8,711 | 7,041 | 5,687 | 4,746 | 4,754 | 4,794 | 4,388 | 3,295 | 3,084 | 2,849 | 2,494 | 1,522 | 1,424 | 1,139 | 12.00 | 18.00 | 17.00 | 13.00 | 11.00 |
Cashflow From Investing | -74.9% | -946 | -541 | -550 | -311 | -1,062 | -351 | -176 | -567 | -147 | -159 | -145 | -510 | -210 | -60.00 | -30.00 | -28.00 | -176 | -18.00 | -82.00 | -171 | - |
Cashflow From Financing | 126.4% | 156,802 | 69,254 | 284 | 1,740 | 107,678 | 61,416 | 48,583 | 10,192 | 118 | 28,416 | 35.00 | 57.00 | 42.00 | 140,117 | 9.00 | 100,124 | 55,794 | 4.00 | 6.00 | 4.00 | - |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues [Abstract] | ||
Total revenue | $ 83 | $ 0 |
OPERATING EXPENSES: | ||
Research and development | (38,258) | (31,091) |
General and administrative | (10,308) | (7,778) |
Total operating expenses | (48,566) | (38,869) |
LOSS FROM OPERATIONS | (48,483) | (38,869) |
OTHER INCOME (EXPENSE), NET | ||
Dividend income | 5,806 | 3,105 |
Other expense, net | (437) | (40) |
Total other income, net | 5,369 | 3,065 |
Net loss | (43,114) | (35,804) |
Net loss attributable to common stockholders—basic | (43,114) | (35,804) |
Net loss attributable to common stockholders— diluted | $ (43,114) | $ (35,804) |
Net loss per share attributable to common stockholders - basic (in USD per share) | $ (1.21) | $ (1.26) |
Net loss per share attributable to common stockholders - diluted (in USD per share) | $ (1.21) | $ (1.26) |
Weighted-average common stock outstanding - basic (in shares) | 35,685,422 | 28,369,453 |
Weighted-average common stock outstanding - diluted (in shares) | 35,685,422 | 28,369,453 |
Revenue, Product and Service [Extensible Enumeration] | License revenue | License revenue |
Service and other revenue | ||
Revenues [Abstract] | ||
Total revenue | $ 83 | $ 0 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 442,443 | $ 331,147 |
Accounts receivable | 226 | 143 |
Prepaid expenses and other current assets | 20,457 | 16,003 |
Total current assets | 463,126 | 347,293 |
Operating lease right-of-use assets | 14,995 | 15,334 |
Property and equipment, net | 4,434 | 4,134 |
Restricted cash | 1,212 | 1,212 |
Other long-term assets | 2,052 | 2,052 |
TOTAL ASSETS | 485,819 | 370,025 |
CURRENT LIABILITIES: | ||
Accounts payable | 4,986 | 5,450 |
Current portion of operating lease liabilities | 1,050 | 1,005 |
Accrued expenses and other current liabilities | 12,682 | 17,918 |
Total current liabilities | 18,718 | 24,373 |
Operating lease liabilities, net of current portion | 13,154 | 13,439 |
Total liabilities | 31,872 | 37,812 |
STOCKHOLDERS' EQUITY: | ||
Preferred stock, par value of $0.0001 per share; $10,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding | 0 | 0 |
Common stock, par value of $0.0001 per share; 200,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 36,067,786 and 31,841,084 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 3 | 3 |
Additional paid-in capital | 878,484 | 713,636 |
Accumulated deficit | (424,540) | (381,426) |
Total stockholders' equity | 453,947 | 332,213 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 485,819 | $ 370,025 |